May 19, 2009 - Invatec announced today the availability of its newly CE-marked coronary balloon, the IN.PACT Falcon paclitaxel-eluting PTCA balloon catheter at the EuroPCR Congress 2009 in Barcelona, Spain.

May 19, 2009 - MVP (Managed Ventricular Pacing), an exclusive programming feature on Medtronic pacemakers that has been effective in reducing unnecessary pacing in patients, was applied in the MVP Trial of implantable cardioverter-defibrillator (ICD) patients.

May 19, 2009 - Volcano Corp. yesterday announced an exclusive worldwide distribution agreement to initiate the formal launch of the Xtract thrombus aspiration catheter, manufactured by Lumen Biomedical.

May 19, 2009 - Pervasis Therapeutics Inc. today announced new preclinical data for its minimally invasive cell therapy, PVS-10200, which is used following an intervention for peripheral arterial disease (PAD), resulted in a statistically significant increased lumen area, reduced intimal area and decreased occlusion compared to control.

May 18, 2009 – Stereotaxis Inc. displayed updated versions of its Odyssey Workstation, Cinema and Connect systems during Hearth Rhythm 2009 in Boston, May 13-16.

May 18, 2009 – Boston Scientific showcased its new Blazer Dx-20, a bidirectional duodecapolar diagnostic catheter, during Heart Rhythm 2009 last week in Boston.

May 18, 2009 - With electrophysiology procedures continuing to grow in a time of increasing economic constraints, the need for cost-effective clinical systems is acute, and to address this need, GE Healthcare introduced three new CardioLab electrophysiology (EP) recording systems that address a broad range of clinical demands at the Heart Rhythm Society meeting, May 13-16 in Boston.

May 18, 2009 - CardioNet Inc. launched SomNet, a new clinical indicator for severe sleep disorders available in the company’s existing Mobile Cardiac Outpatient Telemetry (MCOT) system, during last week’s Heart Rhythm Society’s (HRS) 30th Annual Scientific Sessions in Boston.

May 18. 2009 - TYRX Inc. announced the initial, interim clinical results from its AIGISRX Antibacterial Envelope Retrospective Registry during Heart Rhythm 2009 in Boston last week.

May 18, 2009 – At Heart Rhythm 2009 last week Biotronik said it completed the first enrollment in the pivotal phase of its IMPACT clinical study, which investigates whether the risk of stroke can be reduced in patients being treated for atrial fibrillation with cardiac devices through early detection of these arrhythmias.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now